Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes

Melanoma Research

Volumn 13, Issue 2, 2003, Pages 129-135

  Suzuki, Masataka ^a   Shinkai, Masashige ^a   Honda, Hiroyuki ^a   Kobayashi, Takeshi ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

Immune induction; Induction heating; Intracellular hyperthermia; Magnetite cationic liposomes; Melanoma

Indexed keywords

MAGNETITE; MAGNETITE CATIONIC LIPOSOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HYPERTHERMIC THERAPY; HYSTERESIS; IMMUNE RESPONSE; MAGNETIC FIELD; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR IMMUNITY; TUMOR REGRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS; CATIONS; FERROSOFERRIC OXIDE; HEAT; HSP70 HEAT-SHOCK PROTEINS; HYPERTHERMIA, INDUCED; IRON; LIPOSOMES; MAGNETICS; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; OXIDES; SPLEEN; TEMPERATURE; TIME FACTORS;

EID: 0038580784     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200304000-00004     Document Type: Article

References (23)

1. Chen S, Zhu H, Wetzel WJ, Philbert MA. Spontaneous melanocytosis in transgenic mice. J Invest Dermatol 1996; 106:1145-1151.
2. Cavaliere R, Ciocatto EC, Giovanella BC, Heidelburger C, Jonson RO, Margottini M, et al. Selective heat sensitivity of cancer cells. Cancer 1967; 20:1351-1381.
3. Perez CA, Kopecky W, Rao DV, Baglan R, Mann J. Local microwave hyperthermia and irradiation in cancer therapy: preliminary observations and directions for future clinical trials. Int J Radiat Oncol Biol Phys 1981; 7:765-772.
4. Jordan A, Wust P, Fahling H, John W, Hinz A, Felix R. Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. Int J Hyperthermia 1993; 9:51-68.
5. Mitsumori M, Hiraoka M, Shibata T, Okuno Y, Masunaga S, Koishi M, et al. Development of intra-arterial hyperthermia using a dextran-magnetite complex. Int J Hyperthermia 1994; 6:785-793.
6. Shinkai M, Matsui M, Kobayashi T. Heat properties of magnetoliposomes for local hyperthermia. Jpn J Hyperthermic Oncol 1994; 10:168-177.
7. Shinkai M, Yanase M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study. Jpn J Cancer Res 1996; 87:1179-1183.
8. Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: ex vivo study. Jpn J Cancer Res 1997; 88:630-632.
9. Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study. Jpn J Cancer Res 1998; 89:463-469.
10. Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes. Jpn J Cancer Res 1998; 89:775-782.
11. Owen CS, Sykes NL. Magnetic labeling and cell sorting. J Immunol Methods 1984; 73:41-48.
12. Aruga A, Aruga E, Chang AE. Reduced efficacy of allogeneic versus syngeneic fibroblasts modified to secrete cytokines as a tumor vaccine adjuvant. Cancer Res 1997; 57:3230-3237.
13. Ohno T, Wakabayashi T, Takemura A, Yoshida J, Ito A, Shinkai M, et al. Effective solitary hyperthermic treatment of malignant glioma using stick type CMC-magnetite. In vivo study. J Neuro Oncol 2002; 56:233-239.
14. Shinkai M, Ueno K, Honda H, Kobayashi T. Magnetite needle as heating mediator for intracellular hyperthermia of tumor. Jpn J Hyperthermic Oncol 2002; 18:191-198.
15. Shinkai M, Le B, Honda H, Yoshikawa K, Shimizu K, Saga S, et al. Targeting hyperthermia for renal cell carcinoma using human MN antigen-specific magnetoliposomes. Jpn J Cancer Res 2001; 92:1138-1145.
16. Burdon RH, Slater A, McMahon M, Cato AC. Hyperthermia and the heat-shock proteins of HeLa cells. Br J Cancer 1982; 45:953-963.
17. Sciandra JJ, Subjeck JR. Heat shock proteins and protection of proliferation and translation in mammalian cells. Cancer Res 1984; 44:5188-5194.
18. Castelli C, Ciupitu AM, Rini F, Rivoltini L, Mazzocchi A, Kiessling R, Parmiani G. Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells. Cancer Res 2001; 61:222-227.
19. Blom DJ, De Waard-Siebinga I, Apte RS, Luyten GP, Niederkorn JY, Jager MJ. Effect of hyperthermia on expression of histocompatibility antigens and heat-shock protein molecules on three human ocular melanoma cell lines. Melanoma Res 1997; 1:103-109.
20. Wells AD, Rai SK, Salvato MS, Band H, Malkovsky M, Hsp72-mediated augmentation of MHC class I surface expression and endogenous antigen presentation. Int Immunol 1998; 10:609-617.
21. Ito A, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T. Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia. Cancer Immunol Immunother 2001; 50:515-522.
22. Ito A, Shinkai M, Honda H, Yoshikawa K, Saga S, Wakabayashi T, et al. Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetic nanoparticles. Cancer Immunol Immunother 2003; 52:80-88.
23. Gorelik E, Kim M, Duty L, Henion T, Galili U. Control of metastatic properties of BL6 melanoma cells by H-2Kb gene: immunological and nonimmunological mechanisms. Clin Exp Metastasis 1993; 11:439-452.